Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1986-6-27
pubmed:abstractText
Peripheral blood lymphocyte subsets involved in cytotoxicity to autologous hepatocytes have been characterized by isolation on antibody-coated Petri dishes in autoimmune and HBsAg-positive chronic active hepatitis (CAH). In autoimmune CAH and in HBsAg-positive CAH without HBcAg in liver tissue, cytotoxicity is sustained by non-T lymphocytes and is confined to M1-positive cells bearing Fc receptors: M1 cytotoxicity inhibition by adding aggregated IgG suggests that these cells are responsible for an antibody-dependent cell-mediated mechanism (ADCC). Moreover, when T-enriched fractions were separated in T4, T8 and 5/9 positive subsets, only the first one showed a significant cytotoxicity: T4 positive cells might act as cytotoxic T cells or might be involved in delayed type hypersensitivity (DTH) reactions. Cytotoxic T lymphocytes in HBsAg-positive CAH with HBcAg in liver tissue are confined in T8 positive subset, while helper/inducer T cells (T4 positive or 5/9 positive) seem to play an important role only in the induction of cell-mediated injury against hepatocytes. The inhibition of T cell-cytotoxicity by preincubating liver cells with monoclonal antibody (Mab) anti-HLA AB and not with Mab anti-HLA DR or aggregated IgG supports the involvement of the class I major histocompatibility complex (MHC) expressed on the hepatocyte surface.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0106-9543
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
45-52
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:3487021-Antibodies, Monoclonal, pubmed-meshheading:3487021-Autoimmune Diseases, pubmed-meshheading:3487021-Cytotoxicity, Immunologic, pubmed-meshheading:3487021-Female, pubmed-meshheading:3487021-HLA Antigens, pubmed-meshheading:3487021-HLA-A Antigens, pubmed-meshheading:3487021-HLA-B Antigens, pubmed-meshheading:3487021-HLA-DR Antigens, pubmed-meshheading:3487021-Hepatitis, Chronic, pubmed-meshheading:3487021-Hepatitis B, pubmed-meshheading:3487021-Hepatitis B Surface Antigens, pubmed-meshheading:3487021-Histocompatibility Antigens Class II, pubmed-meshheading:3487021-Humans, pubmed-meshheading:3487021-Hypersensitivity, Delayed, pubmed-meshheading:3487021-Immunoglobulin G, pubmed-meshheading:3487021-Liver, pubmed-meshheading:3487021-Receptors, Fc, pubmed-meshheading:3487021-T-Lymphocytes, pubmed-meshheading:3487021-T-Lymphocytes, Cytotoxic
pubmed:year
1986
pubmed:articleTitle
Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH).
pubmed:publicationType
Journal Article